New Key Statistics Module, Z-Score and F-Score
OTCPK:OCUTF Key Ratios
| Market Cap $ M | 542.62 |
| Enterprise Value $ M | 489.29 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 116.67 |
| Price/Book | 1.05 |
| Price/Sales | 4.74 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 113.00 |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -1.8 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 61.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -22.47 |
| EV-to-EBITDA | -298.20 |
| PEG | -- |
| Shares Outstanding M | 803.92 |
| Net Margin (%) | -19.65 |
| Operating Margin % | -19.36 |
| Pre-tax Margin (%) | -19.60 |
| Quick Ratio | 3.46 |
| Current Ratio | 3.70 |
| ROA % (ttm) | -4.01 |
| ROE % (ttm) | -4.32 |
| ROIC % (ttm) | -4.80 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.19 |
OCUTF Number of Guru Trades
OCUTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:OCUTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:OCUTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ocumension Therapeutics Insider Transactions
No Available Data
News about OTCPK:OCUTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers